UBS Group
ALAB icon

UBS Group’s Astera Labs ALAB Stock Holding History

UBS Group’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387M Sell
802,024
-640,554
-44% -$170M 0.05% 385
2026
Q1 		$158M Sell
1,442,578
-111,378
-7% -$15.9M 0.02% 740
2025
Q4 		$259M Buy
1,553,956
+727,180
+88% +$122M 0.04% 454
2025
Q3 		$162M Buy
826,776
+340,178
+70% +$55.9M 0.03% 701
2025
Q2 		$44M Sell
486,598
-296,789
-38% -$23.4M 0.01% 1636
2025
Q1 		$46.7M Buy
783,387
+187,068
+31% +$17.3M 0.01% 1536
2024
Q4 		$79M Buy
596,319
+587,261
+6,483% +$55.1M 0.01% 1069
2024
Q3 		$475K Sell
9,058
-64,916
-88% -$3.05M ﹤0.01% 5264
2024
Q2 		$4.48M Buy
73,974
+73,360
+11,948% +$5.09M ﹤0.01% 2982
2024
Q1 		$45.6K Buy
+614
New +$45.5K ﹤0.01% 6552

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group's ALAB Position: Q2 2026 in Review

UBS Group reduced its Astera Labs (ALAB) stake by 44% in Q2 2026, selling an estimated $170M and leaving 802,024 shares worth $387M. The position accounts for 0.05% of the portfolio, ranked #385.

UBS Group first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • UBS Group held 802,024 shares of Astera Labs worth $387M as of Q2 2026.
  • UBS Group sold 640,554 Astera Labs shares in Q2 2026, an estimated $170M.
  • Astera Labs made up 0.05% of UBS Group's portfolio in Q2 2026, its #385 holding.
  • UBS Group first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.